Retractable Technologies, Inc.
New York Stock Exchange AmericanCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Thomas J. Shaw
- Full Time Employees
- 201
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 511 Lobo Lane Little Elm TX United States of America 75068-5295
- IPO Date
- May 4, 2001
- CIK
- 0000946563
- Website
- retractable.com
- Similar Companies
- Business
- Retractable Technologies, Inc. (NYSE American: RVP) designs, develops, manufactures and markets safety medical devices featuring automated retraction technology to reduce needlestick injuries and bloodborne pathogen exposure for healthcare workers. The company offers VanishPoint syringes, including insulin, tuberculin, allergy antigen and autodisable variants; Patient Safe syringes and Luer caps; IV safety catheters; blood collection sets and tube holders; EasyPoint needles and blood collection tube holders with needle; small diameter tube adapters; and allergy trays. Incorporated in 1994 and headquartered in Little Elm, Texas, Retractable Technologies serves hospitals, clinics and healthcare providers in the United States, North and South America, and international markets through general line distributors, specialty distributors and national direct marketing. In recent developments, the company received an Innovative Technology designation from Vizient for its EasyPoint Blood Collection Tube Holder with Needle in November 2025; reduced its manufacturing workforce by approximately 7% in April 2025 to save $1.6 million annually in wages and benefits; declared regular dividends to Series II and III Class B Preferred Stock shareholders throughout 2025; hosted U.S. congressional leaders in September 2025 to highlight Texas manufacturing and supply chain capabilities; and reported efforts to increase domestic production amid tariff pressures for 2025.
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Stock Slips Post Q1 Earnings, Sales Decline Y/Y
Retractable Technologies, Inc. Results for the Period Ended March 31, 2026
Head to Head Contrast: Retractable Technologies (NYSE:RVP) & Interpace Biosciences (OTCMKTS:IDXG)
Retractable Technologies, Inc. Announces Workforce Reduction
RVP Stock Plunges Post Q4 Earnings Despite Revenue Growth
Retractable Technologies, Inc. Reports Results for 2025
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2025
Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies Stock Gains Following Q2 Earnings Growth
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
Retractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Zacks Initiates Coverage of Retractable Technologies With Underperform Recommendation
Retractable Technologies, Inc. Results for the Period Ended March 31, 2025
Retractable Technologies, Inc. Announces Reduction in Workforce